Argus raised the firm’s price target on Truist Financial (TFC) to $52 from $51 and keeps a Buy rating on the shares after its Q4 earnings beat.
Morgan Stanley raised the firm’s price target on Truist Financial (TFC) to $56 from $55 and keeps an Equal Weight rating on the shares ...
H.C. Wainwright analyst increased the price target on shares of Verona Pharma (NASDAQ:VRNA) to $60 from the previous target of $42, maintaining a Buy rating on the shares.
Semiconductors have led industrial advancements and aided key applications such as personal computing, data centers, and ...